Shoulder Innovations (SI) Cash from Financing Activities (2024 - 2026)
Shoulder Innovations' (SI) quarterly Cash from Financing Activities came in at -$84000.0 in Q2 2026, down 100.46% on a YoY basis from $18.3 million in Q2 2025, and down 183.17% quarter-over-quarter from $101000.0 in Q1 2026.
Analysis
Shoulder Innovations (SI) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Shoulder Innovations (SI) has reported Cash from Financing Activities for 3 consecutive years, with -$84000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Financing Activities fell 100.46% year-over-year to -$84000.0; the trailing twelve-month figure through Jun 2026 stood at $106.9 million (up 180.18% YoY), and the FY2025 full-year result was $145.0 million, up 219531.82% from the prior year.
- Cash from Financing Activities eased to -$84000.0 in Q2 2026 per SI's latest filing, from $101000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $108.9 million in Q3 2025 and bottomed at -$2.0 million in Q4 2025.
- Historically, Cash from Financing Activities has averaged $20.7 million across 3 years, with a median of $101000.0 in 2026.
- The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities surged 164856.06% in 2025, then plunged 100.46% in 2026.
- Over 3 years, Cash from Financing Activities stood at $66000.0 in 2024, then plunged by 3127.27% to -$2.0 million in 2025, then soared by 95.8% to -$84000.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$84000.0, $101000.0, and -$2.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 185.05 Bn | 179.45 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 124.43 Bn | 119.22 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 118.52 Bn | 109.70 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 104.55 Bn | 101.07 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 67.11 Bn | 66.57 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.60 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 33.97 Bn | 32.52 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Shoulder Innovations | 413.68 Mn | 314.68 Mn | 13.44 Mn | -84,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -84,000.00 |
| Mar 31, 2026 | 101,000.00 |
| Dec 31, 2025 | -2.00 Mn |
| Sep 30, 2025 | 108.87 Mn |
| Jun 30, 2025 | 18.29 Mn |
| Mar 31, 2025 | 19.79 Mn |
| Sep 30, 2024 | 66,000.00 |